Merocarb

Meropenem, the active ingredient in Merocarb, is a carbapenem presented as an injectable solution for intravenous use. It is employed to treat serious bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, and various forms of hospital‑acquired pneumonia in adult patients.

GNH USA supplies Merocarb as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Meropenem is a broad‑spectrum carbapenem antibiotic indicated for severe infections that require intravenous therapy. - Complicated intra‑abdominal infections: provides bacterial eradication to resolve intra‑abdominal sepsis. - Complicated urinary tract infections: eliminates resistant uropathogens causing pyelonephritis and cystitis. - Hospital‑acquired pneumonia: treats lung infections acquired during hospitalization, including ventilator‑associated cases. - Ventilator‑associated pneumonia: targets multidrug‑resistant organisms in intubated patients. - Severe sepsis and septic shock: offers rapid bactericidal activity to control systemic infection.

Adverse reactions may occur with meropenem therapy.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: may be watery and self‑limiting. - Headache: transient and usually resolves without intervention. - Rash: mild skin erythema or pruritus.

Serious or Rare Side Effects: - Seizures: especially in patients with renal impairment or CNS disease. - Anaphylaxis: acute hypersensitivity reaction requiring immediate medical attention. - Clostridioides difficile‑associated diarrhea: severe colitis due to disruption of normal gut flora.

Use meropenem with clinical monitoring and appropriate patient assessment. - Renal function: adjust dose in patients with impaired clearance. - History of seizures: monitor neurologic status closely. - Hypersensitivity: avoid in individuals allergic to β‑lactam antibiotics. - Pregnancy: category B; weigh benefits against potential risks. - Neonates and infants: use with caution and under specialist guidance. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropenem may interact with other medicines, requiring vigilance.

Major Interactions (Avoid): - Valproic acid: carbapenems can reduce serum valproate levels, risking seizure breakthrough. - CNS stimulants (e.g., phenobarbital): increased risk of seizures when combined.

Moderate Interactions (Monitor Closely): - Loop diuretics: additive nephrotoxic potential; monitor renal function. - Aminoglycosides: combined renal toxicity; assess kidney markers. - Warfarin: possible alteration of INR; check coagulation parameters regularly.